-
Qiu Fuyu: From mechanism to evidence-based, let's take a look at how new hypoglycemic drugs can protect the heart and kidney
Time of Update: 2021-06-05
Exploration of SGLT-2 Inhibitors in Kidney Diseases Without DiabetesProfessor Qiu introduced that in the dapagliflozin prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) study, the result of the primary endpoint was a significant reduction in the primary composite endpoint ( eGFR continued to decrease ≥50%, end-stage renal disease, death due to nephropathy or cardiovascular events) reached 39%.
-
, bladder cancer treatment looks forward to new options | Yimai Meng broke the news
Time of Update: 2021-06-04
Recommended reading: The new non-viral gene therapy has been granted fast track qualification by the FDA, and a phase 1/2 clinical trial for the treatment of bladder cancer will be launched.
-
Looking at the impact of the gradual relaxation of social distancing measures on the spread
Time of Update: 2021-05-22
Recently, Hongjie Yu’s research group at Fudan University has made important progress in the field of gradual relaxation of social distancing measures on the influence of people contact patterns and the spread of new coronary pneumonia.
-
Looking back at the classics | 10 years of rapid changes, the new hypoglycemic drug GLP-1RA has traveled in China
Time of Update: 2021-05-09
45%, and it was also found that liraglutide can significantly reduce weight and the risk of hypoglycemia is extremely low, making the proportion of patients reaching the composite endpoint of HbA1c+no weight gain+no hypoglycemia better than the control group [4].
-
Looking at the biology of the new coronavirus from the perspective of Crisp(r) gene editing technology | Cell Press
Time of Update: 2021-03-25
You can find the submission policy of COVID-19-related papers, as well as the papers on the epidemic and virus published in the journals of Cell Press on the resource center page.
-
Cao Xuetao first mentioned the new concept of "look-a-view meta-control group"
Time of Update: 2021-02-23
Cao Xuetao introduced, this review focuses on this new concept, systematically expounds how the micro-environmental signals of tissue organs in the process of cell differentiation, development and stress can be constructed by constructing the cell "look-off metacontrolling group" to build the characteristic functional state of natural immune cells, so as to accurately regulate the natural immune and inflammatory response.
-
Global pharmaceutical giant Pfizer to add code to look for new "money tree"
Time of Update: 2021-02-13
Wu Xiaobin, president of Pfizer China, told reporters at a recent ceremony to mark the 10th anniversary of Pfizer's China research and development center.
In addition to mergers and acquisitions, Pfizer is understood to have spent more than $7 billion a year on research and development in recent years.
-
After taking the drug, the tumor enlarges, indicating that the anti-cancer drug is not effective? Professor Wu Yilong: This new standard should be looked at
Time of Update: 2021-02-03
immunotherapy is a "god drug", the combined side effects will be greater CTLA-4 inhibition approved for the market, marking the rise of a new generation of immunotherapy drugs; Immune therapy, represented by PD-1, increased the survival rate of patients with advanced non-small cell lung cancer by less than 5% to 16% in five years, with more and more amazing clinical data, and immunotherapy was thus known as the "anti-cancer drug".
-
WCLC's a heavy hit! PD-1/L1、RET、MET...... The progress of new drugs at popular targets is a first look
Time of Update: 2021-01-23
5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in PreviouslyTreated, The results of the KEYNOTE-010 study (NCT01905657) published at this meeting of PD-L1-Positive Advanced NSCLC showed that The Pabli pearl monoanti (2 or 10 mg/kg Q3W) significantly improved OS in patients with advanced NSCLC (PD-L1 TPS≥50% and ≥1%) who had previously received treatment.
-
From the Biosecurity Law, we can look at the security of the biopharmaceutical supply chain under the new situation
Time of Update: 2021-01-20
addition to bioreactive devices, China's domestic pharmaceutical process equipment can basically meet the functional requirements of use, but in terms of production quality and productivity, there are still some gaps with foreign imported brands.
-
Plasma coating technology gives the end-of-life engine a new look
Time of Update: 2021-01-19
China Coatings Online News, according to U.S. technology news site Gizmag, Ford is recycling old, broken engines, using its patented plasma coating technology (PTWA), to repair them and refresh them, but also reduce carbon dioxide emissions during the repair process.
-
China's customs authorities have taken strict quarantine measures, and Russian exporters are looking for new markets
Time of Update: 2020-12-22
alexander Efremov, CEO of the Dobroflot Group in Russia, said Chinese customs had stepped up quarantine measures against the COVID-19 virus, extending the unloading time from the previous 5-6 days to three weeks, resulting in a 15 per cent increase in shipping costs.
-
Nature: This winter, the new crown outbreak looks set to get worse
Time of Update: 2020-11-04
Rachel Baker, an epidemiologist at Princeton University, says that even if seasonal factors are small, the main reason for the spread of the new coronavirus is the large number of susceptible people, which means that people in the southern hemisphere, which is about to have summer, should not be complacent.
-
"New use of old medicine": looks hilarious and difficult to do?
Time of Update: 2020-11-03
The most successful examples of drug use changes (repurposing/repositioning, "new use of old drugs") were the "accidental" discovery of the magical effects of Sidinha, and the approval of salicylic amines for the treatment of skin damage caused by leprosy and multiple myeloma.
-
Cosmodry's thermoplastic composites bring a new look and feel to Ulser's cars
Time of Update: 2020-11-03
Take carbon fiber hub inserts as an example, through the back injection of polycarbonate nuts, and the wheel's aluminum spokes fixed, the connection between the components is strong, and the process is easy to achieve .